Financhill
Sell
27

CVS Quote, Financials, Valuation and Earnings

Last price:
$44.37
Seasonality move :
9.63%
Day range:
$43.68 - $44.77
52-week range:
$43.60 - $83.25
Dividend yield:
6%
P/E ratio:
11.26x
P/S ratio:
0.15x
P/B ratio:
0.74x
Volume:
20.9M
Avg. volume:
14.1M
1-year change:
-42.57%
Market cap:
$55.8B
Revenue:
$357.8B
EPS (TTM):
$3.94
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Revenue $256.8B $268.7B $292.1B $322.5B $357.8B
Revenue Growth (YoY) 31.97% 4.65% 8.71% 10.39% 10.95%
 
Cost of Revenues $211.2B $219.7B $240B $268B $303.3B
Gross Profit $45.5B $49B $52.1B $54.5B $54.4B
Gross Profit Margin 17.73% 18.25% 17.84% 16.9% 15.21%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$186M -$1.2B -$2.1B -$8.2B -$768M
Operating Expenses $33.3B $35.1B $37B $38.2B $39.8B
Operating Income $12.2B $13.9B $15.1B $16.3B $14.6B
 
Net Interest Expenses $3B $2.9B $2.5B $2.3B $2.7B
EBT. Incl. Unusual Items $9B $9.8B $10.5B $5.8B $11.2B
Earnings of Discontinued Ops. -- -$9M -- -- --
Income Tax Expense $2.4B $2.6B $2.5B $1.5B $2.8B
Net Income to Company $6.6B $7.2B $8B $4.3B $8.4B
 
Minority Interest in Earnings $3M -$13M $12M -$16M -$24M
Net Income to Common Excl Extra Items $6.6B $7.2B $8B $4.3B $8.3B
 
Basic EPS (Cont. Ops) $5.10 $5.48 $6.07 $3.29 $6.49
Diluted EPS (Cont. Ops) $5.08 $5.46 $6.02 $3.26 $6.47
Weighted Average Basic Share $1.3B $1.3B $1.3B $1.3B $1.3B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.3B $1.3B
 
EBITDA $16.4B $17.1B $17.5B $12.3B $18.2B
EBIT $12B $12.7B $13B $8.1B $13.8B
 
Revenue (Reported) $256.8B $268.7B $292.1B $322.5B $357.8B
Operating Income (Reported) $12.2B $13.9B $15.1B $16.3B $14.6B
Operating Income (Adjusted) $12B $12.7B $13B $8.1B $13.8B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $67.1B $73.8B $81.2B $89.8B $95.4B
Revenue Growth (YoY) 3.47% 10.05% 9.98% 10.6% 6.31%
 
Cost of Revenues $55.3B $61.1B $67.8B $76.2B $82.9B
Gross Profit $11.7B $12.7B $13.4B $13.6B $12.6B
Gross Profit Margin 17.48% 17.21% 16.5% 15.13% 13.16%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$712M -$745M -$7.7B $11M -$1.1B
Operating Expenses $8.5B $9.2B $9.6B $9.9B $10.6B
Operating Income $3.2B $3.5B $3.8B $3.7B $2B
 
Net Interest Expenses $731M $602M $566M $693M $752M
EBT. Incl. Unusual Items $1.8B $2.1B -$4.4B $3B $105M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $587M $558M -$1B $754M $34M
Net Income to Company $1.2B $1.6B -$3.4B $2.3B $71M
 
Minority Interest in Earnings $5M $11M -$7M -$4M $16M
Net Income to Common Excl Extra Items $1.2B $1.6B -$3.4B $2.3B $87M
 
Basic EPS (Cont. Ops) $0.93 $1.21 -$2.59 $1.76 $0.07
Diluted EPS (Cont. Ops) $0.93 $1.20 -$2.59 $1.75 $0.07
Weighted Average Basic Share $1.3B $1.3B $1.3B $1.3B $1.3B
Weighted Average Diluted Share $1.3B $1.3B $1.3B $1.3B $1.3B
 
EBITDA $3.7B $3.9B -$2.8B $4.8B $2B
EBIT $2.5B $2.7B -$3.9B $3.7B $857M
 
Revenue (Reported) $67.1B $73.8B $81.2B $89.8B $95.4B
Operating Income (Reported) $3.2B $3.5B $3.8B $3.7B $2B
Operating Income (Adjusted) $2.5B $2.7B -$3.9B $3.7B $857M
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $266B $285.1B $315.2B $347.8B $368.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $217.3B $234.7B $260.9B $293.4B $316.5B
Gross Profit $48.8B $50.4B $54.4B $54.4B $52.4B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$813M -$1.3B -$9.5B -$858M -$1.1B
Operating Expenses $34.1B $36.4B $38.1B $39.4B $41.7B
Operating Income $14.7B $13.9B $16.2B $15B $10.7B
 
Net Interest Expenses $3B $2.6B $2.3B $2.5B $2.9B
EBT. Incl. Unusual Items $10.9B $10.1B $4.4B $11.6B $6.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.9B $2.5B $991M $3B $1.7B
Net Income to Company $8B $7.6B $3.4B $8.7B $5B
 
Minority Interest in Earnings -$8M -- -$8M -$21M $6M
Net Income to Common Excl Extra Items $8B $7.6B $3.4B $8.6B $5B
 
Basic EPS (Cont. Ops) $6.08 $5.75 $2.50 $6.66 $3.95
Diluted EPS (Cont. Ops) $6.05 $5.72 $2.45 $6.63 $3.94
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA $18.2B $17.2B $11B $18.4B $14.2B
EBIT $13.8B $12.6B $6.7B $14.1B $9.6B
 
Revenue (Reported) $266B $285.1B $315.2B $347.8B $368.9B
Operating Income (Reported) $14.7B $13.9B $16.2B $15B $10.7B
Operating Income (Adjusted) $13.8B $12.6B $6.7B $14.1B $9.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Revenue $199.2B $215.5B $238.6B $264B $275.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $162.1B $177.1B $198B $223.4B $236.6B
Gross Profit $37.1B $38.4B $40.6B $40.6B $38.5B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -$613M -$650M -$8.1B -$790M -$1.1B
Operating Expenses $25.7B $27B $28.1B $29.3B $31.2B
Operating Income $11.4B $11.4B $12.5B $11.2B $7.3B
 
Net Interest Expenses $2.2B $1.9B $1.7B $2B $2.2B
EBT. Incl. Unusual Items $8.5B $8.9B $2.7B $8.5B $4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $2.3B $2.2B $691M $2.1B $1.1B
Net Income to Company $6.2B $6.6B $2B $6.3B $3B
 
Minority Interest in Earnings -$11M $2M -$18M -$23M $7M
Net Income to Common Excl Extra Items $6.2B $6.6B $2B $6.3B $3B
 
Basic EPS (Cont. Ops) $4.74 $5.01 $1.51 $4.90 $2.36
Diluted EPS (Cont. Ops) $4.72 $4.98 $1.47 $4.88 $2.36
Weighted Average Basic Share $3.9B $4B $3.9B $3.9B $3.8B
Weighted Average Diluted Share $3.9B $4B $4B $3.9B $3.8B
 
EBITDA $14.1B $14.1B $7.6B $13.7B $9.7B
EBIT $10.8B $10.7B $4.4B $10.4B $6.2B
 
Revenue (Reported) $199.2B $215.5B $238.6B $264B $275.1B
Operating Income (Reported) $11.4B $11.4B $12.5B $11.2B $7.3B
Operating Income (Adjusted) $10.8B $10.7B $4.4B $10.4B $6.2B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Cash and Equivalents $5.7B $7.9B $9.4B $12.9B $8.2B
Short Term Investments $2.4B $3B $3.1B $2.8B $3.3B
Accounts Receivable, Net $9.4B $9.7B $10.5B $11.7B $15.6B
Inventory $17.5B $18.5B $17.8B $19.1B $18B
Prepaid Expenses -- -- -- -- --
Other Current Assets $5.1B $5.3B $5.3B $2.6B $3.2B
Total Current Assets $50.3B $56.4B $60B $65.6B $67.9B
 
Property Plant And Equipment $32.9B $33.3B $32B $30.7B $30.4B
Long-Term Investments $17.3B $20.8B $23B $21.1B $23B
Goodwill $79.7B $79.6B $79.1B $78.2B $91.3B
Other Intangibles $33.1B $31.1B $29B $24.8B $29.2B
Other Long-Term Assets $4.6B $4.6B $4.7B $4.6B $4.7B
Total Assets $222.4B $230.7B $233B $228.3B $249.7B
 
Accounts Payable $10.5B $11.1B $12.5B $14.8B $14.9B
Accrued Expenses $12.1B $14.2B $17.7B $18.7B $22.2B
Current Portion Of Long-Term Debt $3.8B $5.4B $4.2B $1.8B $2.8B
Current Portion Of Capital Lease Obligations $1.6B $1.6B $1.6B $1.7B $1.7B
Other Current Liabilities $4.8B $5.8B $5.6B $2.8B $2.5B
Total Current Liabilities $53.3B $62B $67.8B $69.4B $79.2B
 
Long-Term Debt $64.7B $59.2B $52B $50.5B $58.6B
Capital Leases -- -- -- -- --
Total Liabilities $158.3B $161B $157.6B $156.5B $173.1B
 
Common Stock $46B $46.5B $47.4B $48.2B $49B
Other Common Equity Adj $1B $1.4B $965M -$1.3B -$297M
Common Equity $63.9B $69.4B $75.1B $71.5B $76.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $306M $312M $306M $300M $175M
Total Equity $64.2B $69.7B $75.4B $71.8B $76.6B
 
Total Liabilities and Equity $222.4B $230.7B $233B $228.3B $249.7B
Cash and Short Terms $8.1B $10.9B $12.5B $15.7B $11.5B
Total Debt $68.5B $64.6B $56.2B $52.3B $61.6B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Cash and Equivalents $9.3B $9.8B $17.2B $13B $6.9B
Short Term Investments $2.8B $3B $2.8B $3.1B $2.8B
Accounts Receivable, Net $10.1B $10.8B $10.4B $13.7B $13.8B
Inventory $17.5B $17.4B $18.1B $18B $17.6B
Prepaid Expenses -- -- -- -- --
Other Current Assets $5.8B $5.3B $2.2B $3.1B $3.8B
Total Current Assets $59.2B $60.8B $68.3B $70.1B $67.3B
 
Property Plant And Equipment $32.8B $33.2B $30.9B $30.6B $29B
Long-Term Investments $20.2B $22.4B $20.6B $21.7B $28.9B
Goodwill $79.6B $79.1B $78.1B $91.3B $91.3B
Other Intangibles $31.7B $29.5B $25.2B $29.6B $27.8B
Other Long-Term Assets $4.6B $4.7B $4.8B $4.8B $4.8B
Total Assets $232.9B $234.9B $231.2B $251.3B $252.4B
 
Accounts Payable $11.7B $12.7B $13.9B $14.9B $15.7B
Accrued Expenses $14.3B $16.1B $19.4B $22.6B $20.2B
Current Portion Of Long-Term Debt $5.4B $1.6B $1.4B $2.1B $4.9B
Current Portion Of Capital Lease Obligations $1.8B $1.8B $1.7B $1.7B $1.9B
Other Current Liabilities $5.5B $5.7B $6.5B $6.2B $2B
Total Current Liabilities $62B $64.7B $72.4B $81.6B $84.6B
 
Long-Term Debt $61.6B $56.8B $50.8B $59.8B $59.8B
Capital Leases -- -- -- -- --
Total Liabilities $163.8B $160.3B $160.2B $176.8B $177.3B
 
Common Stock $46.4B $47.1B $48B $48.8B $49.5B
Other Common Equity Adj $1.3B $1.1B -$1.6B -$1B $209M
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $305M $310M $328M $173M $162M
Total Equity $69.1B $74.6B $71B $74.5B $75.1B
 
Total Liabilities and Equity $232.9B $234.9B $231.2B $251.3B $252.4B
Cash and Short Terms $12.1B $12.8B $20B $16.2B $9.7B
Total Debt $67B $58.4B $52.2B $61.9B $65.5B
Period Ending 2019-12-31 2020-12-31 2021-12-31 2022-12-31 2023-12-31
Net Income to Stockholders $6.6B $7.2B $8B $4.3B $8.4B
Depreciation & Amoritzation $4.4B $4.4B $4.5B $4.2B $4.4B
Stock-Based Compensation $453M $400M $484M $447M $588M
Change in Accounts Receivable -$2.2B -$1.5B -$2.7B -$3B -$6.3B
Change in Inventories -$1.1B -$973M $735M -$1.4B $1.2B
Cash From Operations $12.8B $15.9B $18.3B $16.2B $13.4B
 
Capital Expenditures $2.5B $2.4B $2.5B $2.7B $3B
Cash Acquisitions -$444M -$26M -$146M -$1.4B -$16.6B
Cash From Investing -$3.3B -$5.5B -$5.3B -$5B -$20.9B
 
Dividends Paid (Ex Special Dividend) -$2.6B -$2.6B -$2.6B -$2.9B -$3.1B
Special Dividend Paid
Long-Term Debt Issued $3.7B $10B $987M -- $16.1B
Long-Term Debt Repaid -$9.1B -$15.6B -$10.3B -$4.2B -$8.2B
Repurchase of Common Stock -- -- -- -$3.5B -$2B
Other Financing Activities $59M $337M -$13M -$449M -$382M
Cash From Financing -$7.7B -$7.7B -$11.4B -$10.5B $2.7B
 
Beginning Cash (CF) $6.6B $8.4B $11B $12.7B $13.3B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.9B $2.6B $1.6B $614M -$4.8B
Ending Cash (CF) $8.4B $11B $12.7B $13.3B $8.5B
 
Levered Free Cash Flow $10.4B $13.4B $15.7B $13.5B $10.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $1.2B $1.6B -$3.4B $2.3B $71M
Depreciation & Amoritzation $1.1B $1.1B $1.1B $1.1B $1.2B
Stock-Based Compensation $109M $114M $105M $154M $133M
Change in Accounts Receivable -$1.3B -$1.1B $678M -$3.1B -$3.8B
Change in Inventories -$958M -$420M -$884M -$495M -$1.6B
Cash From Operations $1.9B $5.5B $9.1B $2.7B -$745M
 
Capital Expenditures $534M $608M $580M $545M $670M
Cash Acquisitions $774M -$27M $9M -$18M -$12M
Cash From Investing -$1.4B -$847M -$805M -$771M -$3.3B
 
Dividends Paid (Ex Special Dividend) -$665M -$659M -$726M -$779M -$837M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $4B $987M -- -$1B $600M
Long-Term Debt Repaid -$9.5B -$2.4B -$2.7B -$947M -$1.5B
Repurchase of Common Stock -- -- -- $3M $1M
Other Financing Activities -$31M $32M $12M -$96M $3M
Cash From Financing -$6.1B -$1.9B -$3.2B -$2.7B -$1.6B
 
Beginning Cash (CF) $15.1B $10.3B $12.5B $14.1B $12.8B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -$5.6B $2.7B $5.1B -$752M -$5.7B
Ending Cash (CF) $9.5B $13B $17.6B $13.4B $7.1B
 
Levered Free Cash Flow $1.3B $4.9B $8.5B $2.2B -$1.4B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $8B $7.6B $3.4B $8.7B $5B
Depreciation & Amoritzation $4.4B $4.5B $4.3B $4.3B $4.6B
Stock-Based Compensation $386M $458M $479M $567M $530M
Change in Accounts Receivable -$3.4B -$1.5B -$1.2B -$4.9B -$3.3B
Change in Inventories -$1.4B $79M -$777M $285M $283M
Cash From Operations $14.9B $17.8B $22.1B $14.1B $4.6B
 
Capital Expenditures $2.3B $2.6B $2.6B $2.8B $2.9B
Cash Acquisitions -$77M -$167M -$2.1B -$15.8B -$205M
Cash From Investing -$5B -$5.1B -$6.4B -$19.8B -$8.3B
 
Dividends Paid (Ex Special Dividend) -$2.6B -$2.6B -$2.8B -$3.1B -$3.3B
Special Dividend Paid
Long-Term Debt Issued $8.2B $3B -- $15.9B $5.8B
Long-Term Debt Repaid -$11.2B -$13B -$6.6B -$7.8B -$2.1B
Repurchase of Common Stock -- -- -$2B -$3.5B -$3B
Other Financing Activities $43M $371M -$388M -$378M -$200M
Cash From Financing -$5.7B -$11.7B -$11.2B $1.5B -$2.5B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $4.3B $1.1B $4.5B -$4.2B -$6.2B
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $12.6B $15.2B $19.5B $11.3B $1.7B
Period Ending 2020-09-30 2021-09-30 2022-09-30 2023-09-30 2024-09-30
Net Income to Stockholders $6.2B $6.6B $2B $6.3B $3B
Depreciation & Amoritzation $3.3B $3.4B $3.2B $3.2B $3.5B
Stock-Based Compensation $288M $346M $341M $461M $403M
Change in Accounts Receivable -$3.6B -$3.5B -$2B -$3.9B -$986M
Change in Inventories $45M $1.1B -$415M $1.3B $355M
Cash From Operations $12.3B $14.3B $18.1B $16.1B $7.2B
 
Capital Expenditures $1.7B $1.9B $2B $2.1B $2B
Cash Acquisitions $6M -$135M -$2.1B -$16.5B -$85M
Cash From Investing -$4.3B -$3.8B -$4.9B -$19.6B -$7.1B
 
Dividends Paid (Ex Special Dividend) -$2B -$2B -$2.2B -$2.4B -$2.5B
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $7.9B $987M -- $15.9B $5.6B
Long-Term Debt Repaid -$10.5B -$7.8B -$4.2B -$7.7B -$1.7B
Repurchase of Common Stock -- -- -$2B -$2B -$3B
Other Financing Activities -$115M -$81M -$456M -$385M -$203M
Cash From Financing -$4.4B -$8.4B -$8.3B $3.7B -$1.6B
 
Beginning Cash (CF) $31.4B $30.2B $36.8B $42.4B $31.5B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $3.6B $2B $4.9B $70M -$1.4B
Ending Cash (CF) $35B $32.2B $41.6B $42.5B $30.1B
 
Levered Free Cash Flow $10.6B $12.3B $16.1B $13.9B $5.2B

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock